Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

December 31, 2004

Conditions
Sarcoma
Interventions
DRUG

exatecan mesylate

Trial Locations (10)

1200

Cliniques Universitaires Saint-Luc, Brussels

B-3000

U.Z. Gasthuisberg, Leuven

DK-8000

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade, Aarhus

D-13122

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin

D-01307

Universitatsklinikum Carl Gustav Carl Carus, Dresden

D-45122

Universitaetsklinikum Essen, Essen

D-20246

Universitaets-Krankenhaus Eppendorf, Hamburg

D-30625

Medizinische Hochschule Hannover, Hanover

D-72076

Eberhard Karls Universitaet, Tübingen

833 10

National Cancer Institute - Bratislava, Bratislava

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00041236 - Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter